191 related articles for article (PubMed ID: 20196555)
1. Virtual screening discovery of new acetylcholinesterase inhibitors issued from CERMN chemical library.
Sopkova-de Oliveira Santos J; Lesnard A; Agondanou JH; Dupont N; Godard AM; Stiebing S; Rochais C; Fabis F; Dallemagne P; Bureau R; Rault S
J Chem Inf Model; 2010 Mar; 50(3):422-8. PubMed ID: 20196555
[TBL] [Abstract][Full Text] [Related]
2. Acetylcholinesterase complexed with bivalent ligands related to huperzine a: experimental evidence for species-dependent protein-ligand complementarity.
Wong DM; Greenblatt HM; Dvir H; Carlier PR; Han YF; Pang YP; Silman I; Sussman JL
J Am Chem Soc; 2003 Jan; 125(2):363-73. PubMed ID: 12517147
[TBL] [Abstract][Full Text] [Related]
3. Discovery of acetylcholinesterase peripheral anionic site ligands through computational refinement of a directed library.
Dickerson TJ; Beuscher AE; Rogers CJ; Hixon MS; Yamamoto N; Xu Y; Olson AJ; Janda KD
Biochemistry; 2005 Nov; 44(45):14845-53. PubMed ID: 16274232
[TBL] [Abstract][Full Text] [Related]
4. The complex of a bivalent derivative of galanthamine with torpedo acetylcholinesterase displays drastic deformation of the active-site gorge: implications for structure-based drug design.
Greenblatt HM; Guillou C; Guénard D; Argaman A; Botti S; Badet B; Thal C; Silman I; Sussman JL
J Am Chem Soc; 2004 Dec; 126(47):15405-11. PubMed ID: 15563167
[TBL] [Abstract][Full Text] [Related]
5. Efficient method for high-throughput virtual screening based on flexible docking: discovery of novel acetylcholinesterase inhibitors.
Mizutani MY; Itai A
J Med Chem; 2004 Sep; 47(20):4818-28. PubMed ID: 15369385
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of acetylcholinesterase, beta-amyloid aggregation, and NMDA receptors in Alzheimer's disease: a promising direction for the multi-target-directed ligands gold rush.
Rosini M; Simoni E; Bartolini M; Cavalli A; Ceccarini L; Pascu N; McClymont DW; Tarozzi A; Bolognesi ML; Minarini A; Tumiatti V; Andrisano V; Mellor IR; Melchiorre C
J Med Chem; 2008 Aug; 51(15):4381-4. PubMed ID: 18605718
[TBL] [Abstract][Full Text] [Related]
7. In silico design and search for acetylcholinesterase inhibitors in Alzheimer's disease with a suitable pharmacokinetic profile and low toxicity.
da Silva VB; de Andrade P; Kawano DF; Morais PA; de Almeida JR; Carvalho I; Taft CA; da Silva CH
Future Med Chem; 2011 Jun; 3(8):947-60. PubMed ID: 21707398
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, biological evaluation, and molecular modeling of berberine derivatives as potent acetylcholinesterase inhibitors.
Huang L; Shi A; He F; Li X
Bioorg Med Chem; 2010 Feb; 18(3):1244-51. PubMed ID: 20056426
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of 3,6-diaryl-7H-thiazolo[3,2-b] [1,2,4]triazin-7-one derivatives as acetylcholinesterase inhibitors.
Jin Z; Yang L; Liu SJ; Wang J; Li S; Lin HQ; Wan DC; Hu C
Arch Pharm Res; 2010 Oct; 33(10):1641-9. PubMed ID: 21052939
[TBL] [Abstract][Full Text] [Related]
10. Benzophenone-based derivatives: a novel series of potent and selective dual inhibitors of acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation.
Belluti F; Bartolini M; Bottegoni G; Bisi A; Cavalli A; Andrisano V; Rampa A
Eur J Med Chem; 2011 May; 46(5):1682-93. PubMed ID: 21397996
[TBL] [Abstract][Full Text] [Related]
11. Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation.
Belluti F; Rampa A; Piazzi L; Bisi A; Gobbi S; Bartolini M; Andrisano V; Cavalli A; Recanatini M; Valenti P
J Med Chem; 2005 Jun; 48(13):4444-56. PubMed ID: 15974596
[TBL] [Abstract][Full Text] [Related]
12. Discovery of dual binding site acetylcholinesterase inhibitors identified by pharmacophore modeling and sequential virtual screening techniques.
Gupta S; Fallarero A; Järvinen P; Karlsson D; Johnson MS; Vuorela PM; Mohan CG
Bioorg Med Chem Lett; 2011 Feb; 21(4):1105-12. PubMed ID: 21273074
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
Kwon YE; Park JY; No KT; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY; Kim KH
Bioorg Med Chem; 2007 Oct; 15(20):6596-607. PubMed ID: 17681794
[TBL] [Abstract][Full Text] [Related]
14. Tacrine-based dual binding site acetylcholinesterase inhibitors as potential disease-modifying anti-Alzheimer drug candidates.
Camps P; Formosa X; Galdeano C; Gómez T; Muñoz-Torrero D; Ramírez L; Viayna E; Gómez E; Isambert N; Lavilla R; Badia A; Clos MV; Bartolini M; Mancini F; Andrisano V; Bidon-Chanal A; Huertas O; Dafni T; Luque FJ
Chem Biol Interact; 2010 Sep; 187(1-3):411-5. PubMed ID: 20167211
[TBL] [Abstract][Full Text] [Related]
15. New potential AChE inhibitor candidates.
de Paula AA; Martins JB; dos Santos ML; Nascente Lde C; Romeiro LA; Areas TF; Vieira KS; Gambôa NF; Castro NG; Gargano R
Eur J Med Chem; 2009 Sep; 44(9):3754-9. PubMed ID: 19446931
[TBL] [Abstract][Full Text] [Related]
16. Multipotent drugs with cholinergic and neuroprotective properties for the treatment of Alzheimer and neuronal vascular diseases. I. Synthesis, biological assessment, and molecular modeling of simple and readily available 2-aminopyridine-, and 2-chloropyridine-3,5-dicarbonitriles.
Samadi A; Marco-Contelles J; Soriano E; Alvarez-Pérez M; Chioua M; Romero A; González-Lafuente L; Gandía L; Roda JM; López MG; Villarroya M; García AG; Ríos Cde L
Bioorg Med Chem; 2010 Aug; 18(16):5861-72. PubMed ID: 20656495
[TBL] [Abstract][Full Text] [Related]
17. Construction of the pharmacophore model of acetylcholinesterase inhibitor.
Zhu Y; Tong XY; Zhao Y; Chen H; Jiang FC
Yao Xue Xue Bao; 2008 Mar; 43(3):267-76. PubMed ID: 18630262
[TBL] [Abstract][Full Text] [Related]
18. Tacrine-melatonin hybrids as multifunctional agents for Alzheimer's disease, with cholinergic, antioxidant, and neuroprotective properties.
Fernández-Bachiller MI; Pérez C; Campillo NE; Páez JA; González-Muñoz GC; Usán P; García-Palomero E; López MG; Villarroya M; García AG; Martínez A; Rodríguez-Franco MI
ChemMedChem; 2009 May; 4(5):828-41. PubMed ID: 19308922
[TBL] [Abstract][Full Text] [Related]
19. Molecular interactions of cholinesterases inhibitors using in silico methods: current status and future prospects.
Khan MT
N Biotechnol; 2009 Jun; 25(5):331-46. PubMed ID: 19491049
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of "peripheral" site ligands on Torpedo and chicken acetylcholinesterase.
Eichler J; Anselment A; Sussman JL; Massoulié J; Silman I
Mol Pharmacol; 1994 Feb; 45(2):335-40. PubMed ID: 8114681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
